As Moderna Inc (NASDAQ: MRNA) approaches to manufacture almost one million doses a day, the company has proposed filling COVID-19 vaccine vials with additional doses of up to 15 versus 10 currently to ease the manufacturing crunch, Reuters reports.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,